Arthritis, a complex connective and synovial joint destructive autoimmune disease: Animal models of arthritis with varied etiopathology and their significance

Journal of Postgraduate Medicine

Volumn 60, Issue 3, 2014, Pages 309-317

  Naik, S ^a   Wala, S ^a  

^a Sinhgad Institute of Pharmaceutical Sciences   (India)

Author keywords

Arthritis; osteoarthritis; rheumatoid arthritis

Indexed keywords

AVRIDINE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN; FORMALDEHYDE; FREUND ADJUVANT; PRISTANE; PROTEOGLYCAN;

ADJUVANT ARTHRITIS; ANIMAL MODEL; ARTHRITIS; BACTERIAL CELL WALL; BONE EROSION; CANINE MODEL; CARTILAGE; CONNECTIVE TISSUE; DISEASE MODEL; DNA MODIFICATION; IMMOBILIZATION; NONHUMAN; OSTEOARTHRITIS; POLYARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; STREPTOCOCCUS; SYNOVIAL FLUID; ANIMAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASE; HUMAN;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; HUMANS; MODELS, ANIMAL; OSTEOARTHRITIS;

EID: 84907023509     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.138799     Document Type: Review

References (82)

1. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
2. Brooks PM. The burden of musculoskeletal disease-A global perspective. Clin Rheumatol 2006;25:778-81.
3. Zvaifler NJ. A speculation on the pathogenesis of joint inflammation in rheumatoid arthritis. Arthritis Rheum 1965;8:289-93.
4. Hochberg MC. Epidemiologic considerations in the primary prevention of osteoarthritis. J Rheumatol 1991;18:1438-40.
5. Moskowitz RW, Goldberg VM. Osteoarthritis. In: Schumacher HR, Klippel JH, Robinson DR, editors. Primer on the Rheumatic Diseases. Atlanta, GA: Arthritis Foundation; 1988. p. 171-7.
6. van den Berg WB. The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis. Z Rheumatol 1999;58:136-41.
7. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-47.
8. Frenkel JK. Choice of animal models for the study of disease processes in man. Introduction. Fed Proc 1969;28:160-1.
9. Richardson, JG. A primer of model systems. In: Richardson J, editor. Models of Reality. Mt Airy: Lomond Publications; 1984. p. 1-8.
10. Kim HY, Kim WU, Cho ML, Lee SK, Youn J, Kim SI, et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2085-93.
11. Kim WU, Cho ML, Jung YO, Min SY, Park SW, Min DJ, et al. Type II collagen autoimmunity in rheumatoid arthritis. Am J Med Sci 2004;327:202-11.
12. Kannan K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 2005;12:167-81.
13. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Britti D, De Maio M, et al. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis. Eur Cytokine Netw 2001;12:568-80.
14. Chakradhar LV, Naik SR. Polyamines in inflammation and their modulation by conventional anti-inflammatory drugs. Indian J Exp Biol 2007;45:649-53.
15. Lagishetty CV, Naik SR. Polyamines: Potential anti-inflammatory agents and their possible mechanism of action. Indian J Pharmacol 2008;40:121-5.
16. Naik SR, Sheth UK. Studies on two derivaties of N-Aralkyl-o-ethoxybenzamides: Part II-biochemical studies on their anti-inflammatory activity. Indian J Exp Biol 1978;16:1175-9.
17. Naik SR, Sattur PB, Sheth UK. Studies on two derivatives of N-Aralkyl-o-ethoxybenzamides: Part III-pharmacological and biochemical studies on their anti-Arthritic activity in rat. Indian J Exp Biol 1979;17:1353-6.
18. Naik SR, Naik PM, Chinwala TS, Valame SP, Sheth UK. Some biochemical effects of anti-rheumatic drugs. Biochem Pharmacol 1978;27:353-5.
19. Kalyanpur SG, Pohujani S, Naik SR, Sheth UK. Study of biochemical effects of anti-inflammatory drugs in carrageenin induced oedema and cotton pellet granuloma. Biochem Pharmacol 1968;17:797-803.
20. Newbould BB. Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br J Pharmacol Chemother 1963;21:127-36.
21. Bedwell AE, Elson CJ, Hinton CE. Immunological involvement in the pathogenesis of pristane-induced arthritis. Scand J Immunol 1987;25:393-8.
22. Wilder RL, Remmers EF, Kawahito Y, Gulko PS, Cannon GW, Griffiths MM. Genetic factors regulating experimental arthritis in mice and rats. Curr Dir Autoimmun 1999;1:121-65.
23. Wooley PH, Seibold JR, Whalen JD, Chapdelaine JM. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989;32:1022-30.
24. Hitsumoto Y, Thompson SJ, Zhang YW, Rook GA, Elson CJ. Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis. Autoimmunity 1992;11:247-54.
25. Finnegan A, Mikecz K, Tao P, Glant TT. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J Immunol 1999;163:5383-90.
26. Zhang Y, Guerassimov A, Leroux JY, Cartman A, Webber C, Lalic R, et al. Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for t cell involvement and the immunosuppressive influence of keratan sulfate on recognition of t and b cell epitopes. J Clin Invest 1998;101:1678-86.
27. Banerjee S, Webber C, Poole AR. The induction of arthritis in mice by the cartilage proteoglycan aggrecan: Roles of CD4+ and CD8+ T cells. Cell Immunol 1992;144:347-57.
28. Mikecz K, Glant TT, Buzás E, Poole AR. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum 1990;33:866-76.
29. Wooley PH, Siegner SW, Whalen JD, Karvonen RL, Fernández-Madrid F. Dependence of proteoglycan induced arthritis in BALB/c mice on the development of autoantibodies to high density proteoglycans. Ann Rheum Dis 1992;51:983-91.
30. Oldberg A, Antonsson P, Lindblom K, Heinegård D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 1992;267:22346-50.
31. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992;267:6132-6.
32. DiCesare P, Hauser N, Lehman D, Pasumarti S, Paulsson M. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 1994;354:237-40.
33. Carlsen S, Nandakumar KS, Bäcklund J, Holmberg J, Hultqvist M, Vestberg M, et al. Cartilage oligomeric matrix protein induction of chronic arthritis in mice. Arthritis Rheum 2008;58:2000-11.
34. Holmdahl R, Jonsson R, Larsson P, Klareskog L. Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. Lab Invest 1988;58:53-60.
35. Vingsbo C, Jonsson R, Holmdahl R. Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 1995;99:359-63.
36. Jonsson R, Tarkowski A, Klareskog L. A demineralization procedure for immuno histopathological use. EDTA treatment preserves lymphoid cell surface antigens. J Immunol Methods 1986;88:109-14.
37. Esser RE, Stimpson SA, Cromartie WJ, Schwab JH. Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers. Arthritis Rheum 1985;28:1402-11.
38. Schimmer RC. Schrier DJ, Flory CM, Dykens J, Tung DK, Jacobson PB, et al. Streptococcal cell wall-induced arthritis. Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. J Immunol 1997;159:4103-8.
39. Schrier DJ, Schimmer RC, Flory CM, Tung DK, Ward PA. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls. J Leukoc Biol 1998;63:359-63.
40. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
41. Sano H, Hla T, Maier JA, Crofford LJ, Case JP, Maciag T, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992;89:97-108.
42. Owoyele VB, Adediji JO, Soladoye AO. Anti-inflammatory activity of aqueous leaf extract of Chromolaena odorata. Inflammopharmacology 2005;13:479-84.
43. Kyei S, Koffuor GA, Boampong JN. The efficacy of aqueous and ethanolic leaf extracts of Pistia stratiotes linn in the management of arthritis and fever. J Med Biomed Sci 2012;1:29-37.
44. Bendele AM, Hulman JF. Spontaneous cartilage degeneration in guinea pigs. Arthritis Rheum 1988;31:561-5.
45. Huebner JL, Kraus VB. Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Osteoarthritis Cartilage 2006;14:923-30.
46. Mistry D, Oue Y, Chambers MG, Kayser MV, Mason RM. Chondrocyte death during murine osteoarthritis. Osteoarthritis Cartilage 2004;12:131-41.
47. Walton M. Degenerative joint disease in the mouse knee; radiological and morphological observations. J Pathol 1977;123:97-107.
48. Châteauvert JM, Grynpas MD, Kessler MJ, Pritzker KP. Spontaneous osteoarthritis in rhesus macaques. II. Characterization of disease and morphometric studies. J Rheumatol 1990;17:73-83.
49. Miller LM, Novatt JT, Hamerman D, Carlson CS. Alterations in mineral composition observed in osteoarthritic joints of cynomolgus monkeys. Bone 2004;35:498-506.
50. Smale G, Bendele A, Horton WE Jr. Comparison of age-Associated degeneration of articular cartilage in Wistar and Fischer 344 rats. Lab Anim Sci 1995;45:191-4.
51. Glasson SS, Askew R, Sheppard B, Carito BA, Blanchet T, Ma HL, et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 2004;50:2547-58.
52. Bendele A, McComb J, Gould T, McAbee T, Sennello G, Chlipala E, et al. Animal models of arthritis: Relevance to human disease. Toxicol Pathol 1999;27:134-42.
53. Moskowitz RW, Davis W, Sammarco J, Martens M, Baker J, Mayor M, et al. Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum 1973;16:397-405.
54. Armstrong SJ, Read RA, Ghosh P, Wilson DM. Moderate exercise exacerbates the osteoarthritic lesions produced in cartilage by meniscectomy: A morphological study. Osteoarthritis Cartilage 1993;1:89-96.
55. Lindhorst E, Vail TP, Guilak F, Wang H, Setton LA, Vilim V, et al. Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritis. J Orthop Res 2000;18:269-80.
56. Pond MJ, Nuki G. Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis 1973;32:387-8.
57. Bouchgua M, Alexander K, d'Anjou MA, Girard CA, Carmel EN, Beauchamp G, et al. Use of routine clinical multimodality imaging in a rabbit model of osteoarthritis-part I. Osteoarthritis Cartilage 2009;17:188-96.
58. Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, et al. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 2004;112:83-93.
59. Young RD, Vaughan-Thomas A, Wardale RJ, Duance VC. Type II collagen deposition in cruciate ligament precedes osteoarthritis in the guinea pig knee. Osteoarthritis Cartilage 2002;10:420-8.
60. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005;13:632-41.
61. Hulth A, Lindberg L, Telhag H. Experimental osteoarthritis in rabbits. Preliminary report. Acta Orthop Scand 1970;41:522-30.
62. Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: A dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 1997;40:1670-9.
63. Thakur M, Rahman W, Hobbs C, Dickenson AH, Bennett DL. Characterisation of a peripheral neuropathic component of the rat monoiodoacetate model of osteoarthritis. PloS One 2012;7:E33730.
64. van Osch GJ, van der Kraan PM, Vitters EL, Blankevoort L, van den Berg WB. Induction of osteoarthritis by intra-Articular injection of collagenase in mice. Strain and sex related differences. Osteoarthritis Cartilage 1993;1:171-7.
65. Murat N, Karadam B, Ozkal S, Karatosun V, Gidener S. Quantification of papain-induced rat osteoarthritis in relation to time with the Mankin score. Acta Orthop Traumatol Turc 2007;41:233-7.
66. Havdrup T, Telhag H. Papain-induced changes in the knee joints of adult rabbits. Acta Orthop Scand 1977;48:143-9.
67. Bendele AM, Hulman JF, Harvey AK, Hrubey PS, Chandrasekhar S. Passive role of articular chondrocytes in quinolone-induced arthropathy in guinea pigs. Toxicol Pathol 1990;18:304-12.
68. Ham KD, Loeser RF, Lindgren BR, Carlson CS. Effect of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys. Arthritis Rheum 2002;46:1956-64.
69. Bendele AM. Animal models of osteoarthritis. J Musculoskelet Neuronal Interact 2001;1:363-76.
70. Schaller S, Henriksen K, Hoegh-Andersen P, Søndergaard BC, Sumer EU, Tanko LB, et al. In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: How biomarkers can assist? Assay Drug Dev Technol 2005;3:553-80.
71. Vasseur P. Stifle joint. Anatomy and biomechanics. Cranial cruciate ligament rupture. In: Slatter D, editor. Textbook of Small Animal Surgery. Vol. 2, 2 nd ed. Philadelphia, USA: WB Saunders; 1993. p. 1817-46.
72. Trumble T, Mcllwraith C, Billinghurst R. Technique for arthroscopically guided transection of the cranial cruciate ligament as a model for osteoarthritis. The Eleventh Annual American College of Veterinary Surgeons Symposium, Chicago, Illinois; Veterinary Surgery; 2001. p. 508.
73. McDevitt C, Gilbertson E, Muir H. An experimental model of osteoarthritis; early morphological and biochemical changes. J Bone Joint Surg Br 1977;59:24-35.
74. De Biasi F, Rahal S, Lopes R, Volpi R, Bergamo F. Synovial fluid changes in the dog knee with osteoarthritis induced by Pond and Nuki model. Arq Bras Med Vet Zootec 2001;53:563-7.
75. Otterness IG, Eskra JD, Bliven ML, Shay AK, Pelletier JP, Milici AJ. Exercise protects against articular cartilage degeneration in the hamster. Arthritis Rheum 1998;41:2068-76.
76. Torelli SR, Rahal SC, Volpi RS, Sequera JL, Grassioto IQ. Histopathological evaluation of treatment with chondroitin sulphate for osteoarthritis induced by continuous immobilization in rabbits. J Vet Med A Physiol Pathol Clin Med 2005;52:45-51.
77. Marijnissen AC, van Roermund PM, TeKoppele JM, Bijlsma JW, Lafeber FP. The canine 'groove' model, compared with the ACLT model of osteoarthritis. Osteoarthritis Cartilage 2002;10:145-55.
78. Lahm A, Uhl M, Edlich M, Erggelet C, Haberstroh J, Kreuz PC. An experimental canine model for subchondral lesions of the knee joint. Knee 2005;12:51-5.
79. Pap G, Eberhardt R, Stürmer I, Machner A, Schwarzberg H, Roessner A, et al. Development of osteoarthritis in the knee joints of Wistar rats after strenuous running exercises in a running wheel by intracranial self-stimulation. Pathol Res Pract 1998;194:41-7.
80. Kim HA, Cheon EJ. Animal model of osteoarthritis. J Rheum Dis 2012;19:239-47.
81. Dinser R. Animal models for arthritis. Best Pract Res Clin Rheumatol 2008;22:253-67.
82. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007;213: 626-34.